- Home
- XBIT vs NPT Comparison
XBIT vs NPT Comparison
Compare XBIT & NPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XBIT | NPT |
|---|---|---|
| Founded | 2005 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Specialty Chemicals |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.8M | 64.3M |
| IPO Year | 2015 | 2024 |
Fundamental Metrics
Financial Performance| Metric | XBIT | NPT |
|---|---|---|
| Price | $2.15 | $2.04 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 37.4K | 16.0K |
| Earning Date | 11-11-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $30.47 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.09 | $1.14 |
| 52 Week High | $3.44 | $22.38 |
Technical Indicators
Market Signals| Indicator | XBIT | NPT |
|---|---|---|
| Relative Strength Index (RSI) | 39.61 | 26.07 |
| Support Level | N/A | $1.19 |
| Resistance Level | $2.46 | $3.61 |
| Average True Range (ATR) | 0.07 | 0.22 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 0.00 | 0.52 |
Price Performance
Historical ComparisonAbout XBIT XBiotech Inc.
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
About NPT Texxon Holding Limited Ordinary shares
Texxon Holding Ltd provides technology-enabled supply chain management services to customers in the plastics and chemical industries in East China. The company operates through two segments: Supply Chain Trading and Plastic Manufacturing. Its services include procurement, logistics, payments, and fulfillment for Chinese SMEs, and all revenue is generated from operations within the People's Republic of China.